35
Participants
Start Date
August 31, 2003
Primary Completion Date
September 30, 2008
Study Completion Date
July 31, 2009
irinotecan hydrochloride
Our Lady's Hospital for Sick Children Crumlin, Dublin
Birmingham Children's Hospital, Birmingham
Institute of Child Health at University of Bristol, Bristol
Addenbrooke's Hospital, Cambridge
Leeds Cancer Centre at St. James's University Hospital, Leeds
Leicester Royal Infirmary, Leicester
Royal Liverpool Children's Hospital, Alder Hey, Liverpool
Royal London Hospital, London
Great Ormond Street Hospital for Children, London
Royal Manchester Children's Hospital, Manchester
Sir James Spence Institute of Child Health at Royal Victoria Infirmary, Newcastle upon Tyne
Queen's Medical Centre, Nottingham
Oxford Radcliffe Hospital, Oxford
Children's Hospital - Sheffield, Sheffield
Southampton General Hospital, Southampton
Royal Marsden - Surrey, Sutton
Royal Belfast Hospital for Sick Children, Belfast
Royal Aberdeen Children's Hospital, Aberdeen
Royal Hospital for Sick Children, Edinburgh
Royal Hospital for Sick Children, Glasgow
Childrens Hospital for Wales, Cardiff
Children's Cancer and Leukaemia Group
OTHER